Illumina DRAGEN v4.3 powers most comprehensive, accurate genome with industry-leading innovations
Latest version includes a prebuilt pangenome capturing more genetic diversity, reducing ancestry bias, and improving accuracy SAN DIEGO, June 11,...
DNA
Ancestry Unveils New Collection of Newspaper Articles Related to Enslaved People in the United States Pre-1870
Available to everyone at no cost, the new Articles of Enslavement collection will help descendants of previously enslaved people make...
TRACON Announces Publication in Clinical Cancer Research of Phase 2 Clinical Data for TRC102, a DNA Damage Repair Inhibitor, in Recurrent Glioblastoma Patients
Publication Highlights Activity of the Combination of TRC102 and Temodar (Temozolomide) in Patients who Progressed Following Initial Treatment with Surgical...
Angle PLC Announces Parsortix and Assays being Showcased at EACR 2024
PARSORTIX SYSTEM AND ASSAYS BEING SHOWCASED AT THE 2024 ANNUAL CONGRESS OF THE EUROPEAN ASSOCIATION FOR CANCER RESEARCHANGLE presenting two...
2024 American Oncology Annual Meeting Concludes in Chicago, CANCER CASES SURGE IN WESTERN COUNTRIES, Cancer Driver Interception: Active Prevention Strategy to Reduce Disease Burden
CHICAGO, June 10, 2024 /PRNewswire/ -- The 2024 edition of the American Society of Clinical Oncology (ASCO) Congress highlighted a...
Steve Nuckols Joins ArisGlobal as Chief Customer Officer
Nuckols will apply decades of both life sciences and technology leadership to enhance innovation and customer focus at ArisGlobal BOSTON,...
SeaStar Medical Strengthens Board of Directors and Transitions to Commercial-Stage Company
DENVER, June 10, 2024 (GLOBE NEWSWIRE) -- SeaStar Medical Holding Corporation (Nasdaq: ICU) (SeaStar Medical) announces that three new members...
Defence to Participate in 2024 Society of Nuclear Medicine and Molecular Imaging Annual Meeting in Toronto on June 11, 2024
Vancouver, British Columbia--(Newsfile Corp. - June 10, 2024) - Defence Therapeutics Inc. (CSE: DTC) (OTCQB: DTCFF) (FSE: DTC), ("Defence" or...
deCODE genetics: The rate, nature and transmission of mitochondrial DNA mutations in humans
A new study from deCODE genetics uses pedigrees and sequence data from 64,806 Icelanders to shed light on the rate...
Klick Health Adds 18 Senior Leaders as 27-Year Double-Digit Growth Spurt Continues
Independent health agency continues to attract industry’s brightest minds; fortifies teams companywide as part of commitment to delivering industry-leading innovation,...
Kanazawa University research: Sensing a biomarker
KANAZAWA, Japan, June 7, 2024 /PRNewswire/ -- Researchers at Nano Life Science Institute (WPI-NanoLSI), Kanazawa University report in Biosensors and Bioelectronics: X...
Board-Certified and Highly Accomplished Lasik Surgeon Now Treating Patients at Lasikplus Houston
HOUSTON, TX / ACCESSWIRE / June 6, 2024 / LASIK eye surgeon and Ophthalmology Residency Program Director of the San...
Applied DNA Announces Notice of Allowance for U.S. Patent Covering Fundamental Aspect of its Linea(TM) IVT Platform
Patent covers the Composition of the Company's Proprietary Linea™ RNAP, a Core Technology Empowering the Linea™ IVT PlatformPatent Application Also...
Rett Syndrome Research Trust Launches Roadmap to Cures to Advance Next-Generation Genetic Medicines into Clinical Trials
Roadmap to Cures is an initiative that seeks to raise $40M over the next four years to advance genetic medicine...
First Participants Vaccinated in IMUNON’s IMNN-101 Phase 1 Clinical Trial
DNA vaccine proof-of-concept study expected to demonstrate an “mRNA better” platform LAWRENCEVILLE, N.J., June 05, 2024 (GLOBE NEWSWIRE) -- IMUNON,...
GeneType and Stayhealthy Announce Landmark Distribution Agreement for Revolutionary Multi-Risk Test
MELBOURNE, Australia, June 05, 2024 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (ASX: GTG; NASDAQ: GENE, “Company”, “GTG”), a global leader...
Assembly Biosciences Presents New Data Highlighting Hepatitis D Virus Entry Inhibitor ABI-6250 at the EASL Congress™ 2024
-- Poster highlights promising preclinical profile of ABI-6250 ahead of entry into the clinic, expected by end of 2024 --...
Bioz and Quantabio Launch AI-Driven Citation Widgets to Provide Researchers With Real-Time Application Data
PALO ALTO, CA / ACCESSWIRE / June 5, 2024 / Bioz, Inc., an innovative AI software company based in Silicon...
Syngene launches platform for rapid, enhanced protein production
The new proprietary cell line development platform combines a robust cell line, transposon technology with high throughput clone screening and...
Newport Healthcare Leaders to Present Today at NAMICon, the Annual Conference of the National Alliance on Mental Illness
Thought Leaders Barbara Nosal, PhD, LMFT, LADC, and Don Grant, PhD, MA, MFA, DAC, SUDCC IV, to Address the Impact...